☆ 4.4 Article

Correlation of SARS-CoV-2 Nasopharyngeal CT Values With Viremia and Mortality in Adults Hospitalized With COVID-19

OPEN FORUM INFECTIOUS DISEASES (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

Nikhil Ram-Mohan et al.

Summary: Measurement of SARS-CoV-2 RNA from the plasma of COVID-19 patients using digital polymerase chain reaction can predict disease severity, clinical deterioration, and extrapulmonary complications. It may guide patient triage and management effectively.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes

Jana L. Jacobs et al.

Summary: This study found that SARS-CoV-2 vRNA was detected in the plasma of COVID-19 patients, with the highest rates in ICU patients. Higher levels of vRNA were associated with more severe disease, patient outcomes, and specific inflammatory biomarkers.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Infectious Diseases

Duration of SARS-CoV-2 viremia and its correlation to mortality and inflammatory parameters in patients hospitalized for COVID-19: a cohort study

Karl Hagman et al.

Summary: SARS-CoV-2 viremia at admission is associated with high risk for mortality. The duration of viremia is a significant factor in predicting mortality, with a 40% increased odds for each additional day of viremia.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2022)

Add to Collection

Article Immunology

Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19

Jana L. Jacobs et al.

Summary: Lower respiratory tract (LRT) and plasma viral RNA (vRNA) levels are strongly correlated in mechanically ventilated COVID-19 patients. Delayed LRT vRNA clearance is observed in nonsurvivors. Plasma vRNA may serve as a practical surrogate for LRT vRNA, especially early in critical illness.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Immunology

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019

Reed Magleby et al.

Summary: This study found that the admission SARS-CoV-2 viral load among hospitalized patients with COVID-19 is independently associated with the risk of intubation and in-hospital mortality, with higher viral loads linked to increased mortality and intubation risk.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019

Christian Prebensen et al.

Summary: Detection of severe acute respiratory syndrome coronavirus 2 RNA in the circulation may be associated with disease severity and poor outcomes in patients hospitalized with coronavirus disease 2019.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Serum as Predictor of Severe Outcome in Coronavirus Disease 2019: A Retrospective Cohort Study

Karl Hagman et al.

Summary: Detection of SARS-CoV-2 RNA in serum at hospital admission is associated with a higher risk of progression to critical disease and death in COVID-19 patients. Positive results indicate a poorer outcome.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Emergency Medicine

SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality

Pierrick Le Borgne et al.

Summary: The COVID-19 pandemic has had devastating effects on global healthcare systems. However, measuring viral load on nasopharyngeal swab specimens does not predict disease severity or mortality in COVID-19 patients.

ACADEMIC EMERGENCY MEDICINE (2021)

Add to Collection

Article Immunology

Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality

Emily Happy Miller et al.

Summary: The study found that the viral load of SARS-CoV-2 and duration of symptoms in COVID-19 patients are closely associated with mortality. Patients with higher viral loads have a higher mortality rate, while those who seek medical attention shortly after symptom onset have a worse prognosis.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

Luna Colagrossi et al.

Summary: This proof-of-concept study of 41 SARS-CoV-2-positive adult individuals revealed that patients with viremia had a higher mortality rate, were more frequently affected by haematological malignancies, and had higher viral loads in respiratory samples. This highlights the importance of early identification of high-risk patients for severe COVID-19, particularly among haematologic patients.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19

Maria Dolores Folgueira et al.

Summary: This study compared the infectivity of SARS-CoV-2 in respiratory samples from patients with mild COVID-19 and those with severe bilateral pneumonia. Results showed that severe patients might shed viable virus for up to 4 weeks after symptom onset, even with high cycle threshold values and high neutralizing antibody titres.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Multidisciplinary Sciences

Organ-specific genome diversity of replication-competent SARS-CoV-2

Jolien Van Cleemput et al.

Summary: A detailed virological analysis of thirteen postmortem COVID-19 cases revealed presence of replication-competent SARS-CoV-2 in extrapulmonary organs of immunocompromised patients and identified tissue-specific patterns of genome diversity. Key mutations were found across multiple organs with infectivity confirmed in cell culture. Disease progression was classified into two stages based on duration and viral loads in lungs and plasma.

NATURE COMMUNICATIONS (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load

Judith Berastegui-Cabrera et al.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimating infectiousness throughout SARS-CoV-2 infection course

Terry C. Jones et al.

Summary: In a study of SARS-CoV-2 cases in Germany, it was found that younger subjects had lower viral loads but higher cell culture replication probabilities compared to older subjects. Additionally, 8% of subjects had viral loads above 10(9) copies per swab, with a third of them being presymptomatic, asymptomatic, or mildly symptomatic individuals with a mean age of 37.6 years. The B.1.1.7 lineage infections had a higher viral load and cell culture replication probability than non-B.1.1.7 subjects.

SCIENCE (2021)

Add to Collection

Article Microbiology

Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients

Debby van Riel et al.

Summary: COVID-19 patients with critical disease more frequently exhibit RNAemia compared to those with moderate or severe disease. The presence of viral RNA in serum is associated with elevated levels of inflammatory cytokines and chemokines, indicating that extrarespiratory spread of SARS-CoV-2 contributes to systemic inflammatory responses, playing a crucial role in the systemic pathogenesis of COVID-19.

MSPHERE (2021)

Add to Collection

Article Oncology

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson et al.

Summary: This study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19. Results showed that convalescent plasma treatment was associated with improved 30-day mortality, especially in patients requiring intensive care unit admission or mechanical ventilatory support.

JAMA ONCOLOGY (2021)

Add to Collection

Article Immunology

The first 12 months of COVID-19: a timeline of immunological insights

Thiago Carvalho et al.

Summary: The timeline of major scientific discoveries during the first year of the COVID-19 pandemic highlights the collaborative efforts that led to rapid progress in understanding the immune response to SARS-CoV-2. It showcases the unprecedented convergence of research efforts on COVID-19 and identifies gaps in knowledge for future investigations.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Letter Critical Care Medicine

SARS-CoV-2 viral load predicts COVID-19 mortality

Elisabet Pujadas et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Hematology

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

Thomas Hueso et al.

BLOOD (2020)

Add to Collection

Article Critical Care Medicine

Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

Jesus F. Bermejo-Martin et al.

CRITICAL CARE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.